Register | Forgot password?
Switch to Arabic
Saturday, November 14 - 2009

Delays in diagnosis result in disability for UAE's arthritis sufferers

  • United Arab Emirates: Tuesday, October 28 - 2008 at 13:22
  • PRESS RELEASE

UAE doctors say delays in the diagnosis and treatment of Arthritis can lead to deformities or worse.

Article continues below
 
Health professionals are urging the Ministry of Health to take an active role in the promotion of Rheumatoid Arthritis after local research found 45% of Arthritic patients presented with deformities and disabilities due to a delay in diagnosis and treatment.

Further research has found that 50% of patients in the UAE with Rheumatoid Arthritis are not taking the essential disease modifying medication required to prevent joint damage, compared with only 10% in western populations.

"Early diagnosis ensures measures can be taken to keep the disease under control, prevent joint damage and deformity, and allow patients to better manage the disease."
said Dr. Mahmoud Abdel Fattah, Orthopaedic Surgeon, Emirates Diagnostic Clinic, Welcare Hospital, Dubai.

Local health professionals say sufferers of the disease in the UAE are getting younger and Rheumatoid Arthritis is no longer a disease for the aged.

Rheumatoid Arthritis is a systematic disease which affects the entire body.

Common symptoms include pain and swelling in more than one joint, often affecting the fingers, wrist, elbows, toes, knees, shoulders and ankles.

Health experts believe a lack of general awareness on the community's part, and a significant shortage of practising Rheumatologists in the region, are the main factors contributing to the UAE's poor treatment record.

"The problem is exacerbated in the Middle East because many people do not receive regular health check-ups from family physicians. Patients too easily dismiss back aches, joint stiffness and swelling as 'part of getting older' and do not seek specialist opinion until the disease has progressed to a point where it is debilitating."said Dr. Mahmoud Abdel Fattah.

The study, conducted by doctors from the Dubai Bone & Joint Centre and published in leading European Health Journals, also discovered that UAE-based patients suffering with the ailment had higher than average disease activity levels.
Also consider reading:
Log in to request more information from Pfizer

Notes and media contacts

About Pfizer
Founded in 1849, Pfizer is the world's largest research-based pharmaceutical company taking new approaches to better health. The company discovers, develops, manufactures and delivers quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. At Pfizer, nearly 90,000 colleagues in more than 90 countries work every day to help people stay happier, healthier and longer. Worldwide, Pfizer provides treatment for over 38 million patients a day. The company's overarching purpose: Working Together for a Healthier World.

For more information, please contact:
Lucy Hambour
Consultant
Wallis Marketing Consultants
P.O. Box 502281
Dubai, United Arab Emirates
Tel: +971 4 390 1950
Fax: +971 4 367 2801

Disclaimer:

Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com

Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.

For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions